— Know what they know.
Not Investment Advice

PRME NASDAQ

Prime Medicine, Inc.
1W: -5.8% 1M: -25.5% 3M: -9.8% YTD: -16.4% 1Y: +150.0% 3Y: -76.5%
$2.97
+0.02 (+0.68%)
After Hours: $3.21 (+0.24, +8.08%)
Weekly Expected Move ±7.3%
$3 $3 $3 $3 $3
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Sell · Power 26 · $536.4M mcap · 59M float · 4.28% daily turnover · Short 65% of daily vol
Last Earnings 2026-05-07
EPS
$-0.28
▼ Miss -16.7%
Revenue
$856K
▼ Miss -63.2%
Next Earnings 2026-08-06
EPS Estimate
$-0.26
Range: $-0.31 - $-0.22
Revenue Estimate
$2M
8 analysts

Estimate vs Actual

Earnings Surprise History

5/18
EPS Beats
1/18
Revenue Beats
28%
EPS Beat Rate
6%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-05-15 quarter 2026-12-31 $-0.23 $-0.23 $3,842,182 $3,842,182
2026-05-15 annual 2026-12-31 $-1.00 $-1.00 $12,979,000 $12,929,167
2026-05-15 annual 2027-12-31 $-0.91 $-0.91 $22,617,146 $22,515,438
2026-05-15 annual 2028-12-31 $-0.81 $-0.81 $31,503,123 $31,306,579
2026-05-13 quarter 2027-03-31 $-0.19 $-0.29 ▼ 0.10 $1,158,000 $526,500
2026-05-13 quarter 2026-12-31 $-0.24 $-0.23 ▲ 0.01 $6,320,800 $3,842,182
2026-05-13 quarter 2028-06-30 $-0.19 $-0.21 ▼ 0.02 $1,158,000 $856,000
2026-05-13 quarter 2027-12-31 $-0.19 $-0.29 ▼ 0.10 $1,158,000 $702,000
2026-05-13 quarter 2027-06-30 $-0.19 $-0.28 ▼ 0.09 $1,158,000 $702,000
2026-05-13 annual 2030-12-31 $-0.78 $-0.82 ▼ 0.04 $60,300,000 $60,058,400
2026-05-13 annual 2029-12-31 $-0.90 $-0.93 ▼ 0.03 $18,658,000 $18,356,000
2026-05-13 quarter 2026-09-30 $-0.24 $-0.23 ▲ 0.01 $5,912,000 $7,646,400
2026-05-13 quarter 2028-09-30 $-0.19 $-0.21 ▼ 0.02 $1,158,000 $856,000
2026-05-13 quarter 2027-09-30 $-0.19 $-0.28 ▼ 0.09 $1,158,000 $702,000
2026-05-13 quarter 2026-03-31 $-0.25 $-0.25 $2,328,667 $2,328,667
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms